Semax

No. Semax is not an FDA-approved drug, and it has not been evaluated by the FDA for the diagnosis, treatment, cure, or prevention of any disease. We treat it as investigational and part of an individualized wellness plan. Most research has been done in Russia, focused on cognitive recovery after stroke and on attention and stress resilience under cognitive load. The mechanistic work, including action at melanocortin receptors and upregulation of brain-derived neurotrophic factor, is mostly preclinical, with some human plasma BDNF data from stroke trials. That is a thinner evidence base than a prescription drug, and we would rather say so. The peptide is sourced from specialty peptide distributors that perform Certificate of Analysis testing on every lot for identity, purity, and concentration, and it is prescribed and supervised by Dr. Oliver Morris, Medical Director.

Patients tend to describe the absence of a wall rather than a rush. Reported effects include sharper focus and sustained attention during long work sessions, less mental fatigue late in a demanding day, better stress resilience under heavy cognitive load, and a subjective lift in motivation and follow-through. Most people notice something in the first week rather than after a month. Response is individual and we don't guarantee outcomes. It is worth setting expectations in the other direction too. If you are not noticing anything by week two, the protocol probably isn't doing what you wanted, and we would revisit rather than extend the course. Semax also doesn't fix a sleep debt or a caffeine problem, and patients who haven't addressed those usually get the least out of it.

No, and we don't position it that way. Semax is a synthetic peptide based on a fragment of adrenocorticotropic hormone, ACTH 4-10, modified to last longer in the body. It is not a prescription stimulant and it is not a treatment for a diagnosed attention condition. Patients describe focus and reduced mental fatigue rather than the wired feeling stimulants produce. That said, we are cautious in patients already on stimulants or antidepressants, or with active psychiatric conditions. Effects on dopamine and serotonin systems are documented in preclinical work, and how those interactions behave in real people is not well characterized. If you have a diagnosed attention or mood condition that benefits from established care, Semax is not a substitute for it, and we would say that plainly.

Short cycles, typically two to four weeks on, with extended breaks between courses. It is a once-daily subcutaneous injection into the abdomen, with the dose determined by your provider rather than a fixed number. We don't run it continuously, and that isn't an arbitrary rule. The published clinical work, even at therapeutic doses for stroke recovery, uses short courses with breaks. The peptide clears from blood quickly, but its functional effects in the brain last longer than that clearance would suggest. The cycle length matches how patients actually use it: a hard quarter at work, a study period, a heavy training block, a long stretch of difficult shifts. Starting before the demanding stretch makes more sense than starting halfway through one.

Because the injectable form is what we use in this practice, and the difference deserves to be stated rather than skipped. Most published Semax work is intranasal. Human dosing data for the subcutaneous route is limited. We dose it daily into the abdomen during short courses. That gap between the literature and the route in front of you is part of why we treat Semax as investigational, keep cycles short, and stay selective about who is a candidate. During the consultation we walk through what the evidence supports and where it thins out. If the uncertainty doesn't sit well with you, that is a reasonable conclusion, and we would rather you reach it before starting than after.

Most patients who pursue it have a defined demanding stretch coming: a quarter, a project, a difficult schedule. They have already handled the basics around sleep and caffeine and want a short tool that fits that specific window rather than an open-ended prescription. We are more cautious with patients who have active psychiatric conditions or who are on antidepressants or stimulants. It is avoided in pregnancy and breastfeeding, where no safety data exists. One thing we look for during intake is whether something else explains the symptoms. Focus and stamina often have a hormonal layer underneath, which is why some patients run Semax alongside testosterone optimization or wellness injectables instead of expecting the peptide to carry everything.